Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
P/E Ratio HistoryNormalizing
Percentile Rank31
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-3.11
Near historical average
Percentile
P31
Within normal range
Streak
2 yr
Consecutive declineNormalizing
Average
-2.87
Historical baseline
PeriodValueYoY Change
2025-3.11-80.9%
2024-1.72-2045.8%
2023-0.08+93.0%
2022-1.14+45.8%
2021-2.10+31.2%
2020-3.05+84.1%
2019-19.17-583.6%
2018-2.80-156.5%
20174.96+1152.0%
2016-0.47-